Environmental

EW’s environmental profile is supported by a relatively low capital-intensity footprint versus many healthcare peers, limiting direct emissions and resource-use exposure in operations.

The company’s R&D-to-revenue intensity is high, which can support product innovation with lower incremental environmental burden than peers reliant on heavier manufacturing assets.

Low leverage reduces pressure to prioritize short-term cost cutting over longer-horizon environmental investments, improving resilience versus more indebted peers.

No major environmental controversy or structurally elevated transition-risk signal is evident in the provided metrics, leaving EW positioned better than many diversified healthcare comparables.

Social

EW’s focus on medical technology supports a favorable social profile versus peers because its products are directly tied to patient outcomes and clinical utility.

High R&D intensity indicates sustained investment in product development, which can strengthen patient safety, usability, and long-term stakeholder trust relative to slower-innovating peers.

Stock-based compensation remains modest versus revenue, suggesting less dilution of employee alignment and a more disciplined capital-allocation profile than many growth-oriented peers.

No material social controversy is indicated in the provided data, so EW’s social positioning appears stronger than peers with higher labor, product, or access-related risk.

Governance

EW’s very low debt-to-equity ratio indicates conservative balance-sheet governance, reducing creditor pressure and improving oversight flexibility versus more leveraged peers.

Negative net debt to EBITDA suggests excess liquidity, which supports governance resilience by lowering refinancing risk and constraining aggressive capital structure decisions.

Modest stock-based compensation relative to revenue points to comparatively restrained executive and employee equity dilution, aligning incentives more cleanly than peers with heavier issuance.

The absence of visible governance red flags in the supplied metrics supports a stronger relative governance profile than peers with higher leverage or weaker capital discipline.

Overall Score

EW’s ESG positioning is stronger than many healthcare peers because conservative leverage, disciplined compensation, and sustained R&D support a broadly resilient profile.

Score Driver: Conservative Balance-Sheet Governance Combined With Sustained Innovation Investment